Status:
UNKNOWN
PRALIMAP-CINeCO: Comparison of Health E-coaching Versus Referral to the Usual Care System
Lead Sponsor:
Central Hospital, Nancy, France
Collaborating Sponsors:
University of Lorraine
Cnam-ISTNA
Conditions:
Overweight and Obesity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study involves young adults from the PRALIMAP-INES trial and student volunteers from the University of Lorraine, who are overweight or obese. For young adults from the PRALIMAP-INES trial, the p...
Eligibility Criteria
Inclusion
- Among the young adults who agreed to participate in follow-up visit (T3) in the PRALIMAP-CINeCO trial (Part 1), the inclusion criteria for the inclusion criteria for the proposed research are as follows:
- Person having received complete information on the organization of the research and not and who did not object to their participation and to the use of their data to participate and to use their data
- Have agreed to complete the pre-test questionnaire prior to/at the follow-up visit (T3)
- Have agreed to the anthropometric measurements without invasive intervention performed at the follow-up visit (Q3)
- Have a BMI greater than 25kg/m² (Cole et al. 2000) or a percentage of body fat mass greater than or equal to 20% for men and greater than or equal to 33% for women, depending on age and greater than or equal to 33% for women and not receiving medical medical care for this situation
- Agree to participate in the follow-up
- Accepting the health e-coaching/orientation to routine care
- Affiliated to a social security system or beneficiary of such a system
- Reside in France
- Among the students who agreed to participate, through the Student Health Service of the University of Lorraine, the inclusion criteria for the proposed research are as follows:
- Person having received complete information on the organization of the research and not and who did not object to their participation and to the use of their data to participate and to use their data
- Have agreed to complete the pre-test questionnaire prior to/at the follow-up visit (T0)
- Have agreed to the anthropometric measurements without invasive intervention performed at the follow-up visit (T0)
- Have a BMI greater than 25kg/m² (Cole et al. 2000) or a percentage of body fat mass greater than or equal to 20% for men and greater than or equal to 33% for women, depending on age and greater than or equal to 33% for women and not receiving medical medical care for this situation
- Agree to participate in the follow-up
- Accepting the health e-coaching/orientation to routine care
- Affiliated to a social security system or beneficiary of such a system
- Reside in France
- Be of legal age (18 years or older)
- Be a student at the Université de Lorraine
Exclusion
- If the follow-up visit n°3 (T3) during the PRALIMAP-CINeCO trial (1st part) or the inclusion visit (T0 for University of Lorraine students), was completed, the non-inclusion criteria for the referral of young adults young adults (health e-coaching/current care) are as follows:
- Do not feel the need for coaching
- Be already being treated for overweight by a health professional specializing in the treatment of specialized in the treatment of overweight and obesity or a specialized specialized medical structure/service
- Do not agree to participate in the continuation of PRALIMAP-CINeCO
- Major person under a legal protection measure (guardianship, curatorship, safeguard of justice)
- Persons deprived of liberty by a judicial or administrative decision administrative decision Persons under psychiatric care in accordance with Articles L. 3212-1 and L. 3213-1 of the Public Health Code
Key Trial Info
Start Date :
January 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 9 2025
Estimated Enrollment :
384 Patients enrolled
Trial Details
Trial ID
NCT05399407
Start Date
January 9 2023
End Date
January 9 2025
Last Update
October 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Nancy
Nancy, France, 54000